bioRxivPharmacology & Toxicology
Navigating in vitro bioactivity data: investigating available resources using model compounds
S. Ilmjarv, F. Augsburger, J. T. Bolleman, R. Liechti, A. Bridge, J. Sandstrom, V. Jaquet, I. Xenarios, K.-H. Krause
Abstract
Modern medicine and an increasingly complex environment contribute to exposure of humans to a large number of chemical compounds, that can potentially be toxic. Although widely used, compound testing in animals has important limitations. In vitro testing provides a promising alternative. However, because of the relative inaccessibility and fragmentation of available data, the in vitro approach largely underperforms its potential. The aim of this study is to investigate how available public online resources (tools and databases) support accessing and distribution of in vitro compound data. We examined 19 public online resources, mapped their features, and evaluated their usability with a set of four model compounds (aspirin, rosiglitazone, valproic acid, and tamoxifen). By investigating compound names and identifiers, we observed extensive variation and inconsistencies in available resources: the synonyms were different, compounds structural identifiers (InChI, InChIKey, SMILES and IUPAC systematic name) underperformed in omics databases, identification of compound related metadata (e.g. concentrations used in the experiments) from omics experiments was complex and none of the available resources clearly distinguished between in vivo and in vitro data. In addition, we estimated accessibility of selected public resources using computational queries. Only a few public resources provided access to compound-related data using semantic web technology. The general quality of experiment annotations created further difficulties in identifying data of interest. Therefore, we identified several standardized ontologies with potential to provide an increased accuracy for extensive data retrieval of in vitro compound data. Furthermore, using the examples of our model compounds, we provide recommendations on the use of ontologies by suggesting specific ontology terms to annotate in vitro experimental data when being published.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ToxCastLite: A portable semantic evidence graph linking in vitro bioactivity, in vivo toxicity, and exposure-use context
Arif Dönmez, Oleksiy Nosov, … Katharina Koch·bioRxiv·May 19, 2026
- Toxicity by Consortium Revisited: Structural Neighbors and Cross-Family Reach
Steven M. Muskal, Sanjiv Kumar Jha, … Prashant Tyagi·bioRxiv·Oct 14, 2026
- ANDROMEDA by Prosilico Software Successfully Predicts Human Clinical Pharmacokinetics of 300 Drugs Out of Reach for In Vitro Methods
U. Fagerholm, S. Hellberg, … O. Spjuth·bioRxiv·Oct 5, 2022
- RAID: Regression Analysis based Inductive DNA microarray for Precise Read-Across
- Utilizing virtual experiments to increase understanding of discrepancies involving in vitro-in vivo predictions of hepatic clearance
P. Krishnan, A. K. Smith, … C. A. Hunt·bioRxiv·Oct 9, 2020
- An analysis of laboratory variability and thresholds for human in vitro ADME/PK methods
U. Fagerholm·bioRxiv·Sep 27, 2022